2 results
Approved WMOCompleted
To evaluate the safety and efficacy of PRX-102 compared to agalsidase beta in Fabry disease patients with impaired renal function.
Approved WMOCompleted
The main objective of this trial is to investigate safety of long term use of inhaled molgramostim by collecting information on the side effects.